© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 4, 308-315,
February 19, 2003
© 2003 Oxford University Press
ARTICLE |
Repair of UV Light-Induced DNA Damage and Risk of Cutaneous Malignant Melanoma
Affiliations of authors: Q. Wei, S. S. Strom, L. Wang, Z. Guo, Y. Qiao, C. I. Amos, M. R. Spitz (Department of Epidemiology), J. E. Lee, J. E. Gershenwald, M. I. Ross, P. F. Mansfield (Department of Surgical Oncology), M. Duvic (Department of Dermatology), The University of Texas M. D. Anderson Cancer Center, Houston.
Correspondence to: Qingyi Wei, M.D., Ph.D., Department of Epidemiology, Unit 189, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030 (e-mail: qwei{at}mdanderson.org).
Background: The mechanism underlying the role of UV light exposure from sunlight in the etiology of cutaneous malignant melanoma (CMM) is unclear. Patients with xeroderma pigmentosum, a disease characterized by severe sensitivity to UV radiation and a defect in nucleotide excision repair, have a high incidence of CMM, which suggests that DNA repair capacity (DRC) plays a role in sunlight-induced CMM in the general population as well. Methods: We conducted a hospital-based casecontrol study of DRC and CMM among 312 non-Hispanic white CMM patients who had no prior chemotherapy or radiation therapy, and 324 cancer-free control subjects who were frequency-matched to case patients on age, sex, and ethnicity. Information on demographic variables, risk factors, and tumor characteristics was obtained from questionnaires and medical records. We used the host-cell reactivation assay to measure the DRC in study subjects lymphocytes. All statistical tests were two sided. Results: Case patients had a 19% lower mean (± standard deviation [SD]) DRC (8.5 ± 3.4%) than control subjects (10.5 ± 5.1%), a statistically significant difference (P<.001). DRC that was at or below the median value (i.e., 9.4%) in control subjects was associated with increased risk for CMM after adjustment for age, sex, and other covariates (odds ratio [OR] = 2.02, 95% confidence interval [CI] = 1.45 to 2.82). We observed a doseresponse relationship between decreased DRC and increased risk of CMM (Ptrend<.001). Patients with tumors on sun-exposed skin had statistically significantly lower DRC than patients with tumors on unexposed skin (8.2 ± 3.3% versus 9.5 ± 3.5%; P = .004). Conclusions: Reduced DRC is an independent risk factor for CMM and may contribute to susceptibility to sunlight-induced CMM among the general population.
This article has been cited by other articles:
![]() |
H. Zhao, L.-E Wang, D. Li, R. M. Chamberlain, E. M. Sturgis, and Q. Wei Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis Carcinogenesis, August 1, 2008; 29(8): 1560 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hopkins, D. W. Cescon, D. Tse, P. Bradbury, W. Xu, C. Ma, P. Wheatley-Price, J. Waldron, D. Goldstein, F. Meyer, et al. Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 490 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-E Wang, C. Li, S. S. Strom, L. H. Goldberg, A. Brewster, Z. Guo, Y. Qiao, G. L. Clayman, J. J. Lee, A. K. El-Naggar, et al. Repair Capacity for UV Light Induced DNA Damage Associated with Risk of Nonmelanoma Skin Cancer and Tumor Progression Clin. Cancer Res., November 1, 2007; 13(21): 6532 - 6539. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-T. Bau, Y.-C. Mau, S.-l. Ding, P.-E. Wu, and C.-Y. Shen DNA double-strand break repair capacity and risk of breast cancer Carcinogenesis, August 1, 2007; 28(8): 1726 - 1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, Q. Wei, Q. Shi, Z. Guo, Y. Qiao, and M. R. Spitz A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma Carcinogenesis, July 1, 2007; 28(7): 1430 - 1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, W. Zhou, B. Y. Yeap, L. Su, J. C. Wain, J. M. Poneros, N. S. Nishioka, T. J. Lynch, and D. C. Christiani XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk Carcinogenesis, June 1, 2007; 28(6): 1254 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Povey, F. Darakhshan, K. Robertson, Y. Bisset, M. Mekky, J. Rees, V. Doherty, G. Kavanagh, N. Anderson, H. Campbell, et al. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma Carcinogenesis, May 1, 2007; 28(5): 1087 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, Z. Hu, Z. Liu, L.-E Wang, S. S. Strom, J. E. Gershenwald, J. E. Lee, M. I. Ross, P. F. Mansfield, J. N. Cormier, et al. Polymorphisms in the DNA Repair Genes XPC, XPD, and XPG and Risk of Cutaneous Melanoma: a Case-Control Analysis Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2526 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. A. Abdel-Malek, A. L. Kadekaro, R. J. Kavanagh, A. Todorovic, L. N. Koikov, J. C. McNulty, P. J. Jackson, G. L. Millhauser, S. Schwemberger, G. Babcock, et al. Melanoma prevention strategy based on using tetrapeptide {alpha}-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity FASEB J, July 1, 2006; 20(9): 1561 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Millikan, A. Hummer, C. Begg, J. Player, A. R. de Cotret, S. Winkel, H. Mohrenweiser, N. Thomas, B. Armstrong, A. Kricker, et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study Carcinogenesis, March 1, 2006; 27(3): 610 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-E Wang, P. Xiong, S. S. Strom, L. H. Goldberg, J. E. Lee, M. I. Ross, P. F. Mansfield, J. E. Gershenwald, V. G. Prieto, J. N. Cormier, et al. In Vitro Sensitivity to Ultraviolet B Light and Skin Cancer Risk: A Case-Control Analysis J Natl Cancer Inst, December 21, 2005; 97(24): 1822 - 1831. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Landi, P. A. Kanetsky, S. Tsang, B. Gold, D. Munroe, T. Rebbeck, J. Swoyer, M. Ter-Minassian, M. Hedayati, L. Grossman, et al. MC1R, ASIP, and DNA Repair in Sporadic and Familial Melanoma in a Mediterranean Population J Natl Cancer Inst, July 6, 2005; 97(13): 998 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Keller, A. V. Schally, T. Gaiser, A. Nagy, B. Baker, G. Westphal, G. Halmos, and J. B. Engel Human Malignant Melanomas Express Receptors for Luteinizing Hormone Releasing Hormone Allowing Targeted Therapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogue Cancer Res., July 1, 2005; 65(13): 5857 - 5863. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Blankenburg, I. R. Konig, R. Moessner, P. Laspe, K.-M. Thoms, U. Krueger, S. G. Khan, G. Westphal, C. Berking, M. Volkenandt, et al. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study Carcinogenesis, June 1, 2005; 26(6): 1085 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sarkar-Agrawal, I. Vergilis, N. E. Sharpless, R. A. DePinho, and T. M. Runger Impaired Processing of DNA Photoproducts and Ultraviolet Hypermutability With Loss of p16INK4a or p19ARF J Natl Cancer Inst, December 1, 2004; 96(23): 1790 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hazarika, M. F. McCarty, V. G. Prieto, S. George, D. Babu, D. Koul, M. Bar-Eli, and M. Duvic Up-regulation of Flotillin-2 Is Associated with Melanoma Progression and Modulates Expression of the Thrombin Receptor Protease Activated Receptor 1 Cancer Res., October 15, 2004; 64(20): 7361 - 7369. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Shi, L.-E. Wang, M. L. Bondy, A. Brewster, S. E. Singletary, and Q. Wei Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients Carcinogenesis, September 1, 2004; 25(9): 1695 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hu, F. Ma, F. Collado-Mesa, and R. S. Kirsner UV Radiation, Latitude, and Melanoma in US Hispanics and Blacks Arch Dermatol, July 1, 2004; 140(7): 819 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Hu, M. C. Hall, L. Grossman, M. Hedayati, D. L. McCullough, K. Lohman, and L. D. Case Deficient Nucleotide Excision Repair Capacity Enhances Human Prostate Cancer Risk Cancer Res., February 1, 2004; 64(3): 1197 - 1201. [Abstract] [Full Text] [PDF] |
||||






